register

News & Trends - MedTech & Diagnostics

First patients benefit from Elekta’s cutting-edge technology

Health Industry Hub | April 9, 2021 |

MedTech News: The first Gamma Knife to be installed in Victoria, at Peter MacCallum Cancer Centre, is now fully operational with the first patients to receive the non-invasive radiosurgery.

Elekta’s Gamma Knife is a cutting-edge technology that uses radiation to precisely target and treat tumours and other neurological conditions. It is an alternative to traditional brain surgery and whole brain radiation therapy for the treatment of complex, difficult-to-access brain conditions.

Peter Mac Department of Radiation Oncology Deputy Director and lead clinician for the Victorian Gamma Knife Service, Dr Claire Phillips said the first patients had been referred and treated within the new Victorian Gamma Knife Service based at Peter Mac.

“The Gamma Knife is completely non-invasive and in just one session, without the use of anaesthesia, we can precisely target and treat one or multiple tumours, with the patient going home straight afterwards,” Dr Phillips said.

“Early patient results are positive, and this cutting-edge technology will improve the lives of hundreds of Victorians whose treatment was previously considered off limits to even the most skilled surgeons.”

Florence Lagier was booked for neurosurgery for her vestibular schwannoma (sometimes called acoustic neuroma) when, in late 2020, she learned that Gamma Knife was coming to Peter Mac.

“I asked to have the Gamma Knife procedure instead of the invasive surgery,” Ms Lagier said.

“My recovery time would have been six to eight weeks however, with the Gamma Knife, the recovery time is nil and I can go home the same day with less stress for me and my family.”

The Gamma Knife is a stereotactic radiotherapy machine designed specifically to treat the head. It can treat tumours, vascular malformations and other abnormalities – with minimal effect on healthy tissue.

It also offers a benefit over other forms of radiotherapy which typically require the patient to return for many successive treatment sessions to receive the required therapeutic dose.

The Gamma Knife at Peter Mac is the first in Victoria and only the third in Australia, and Victoria’s Gamma Knife service expected to treat up to 500 patients per year. The other two sites with Gamma Knife include Princess Alexandra Hospital in Brisbane and Macquarie University Hospital in Sydney.

The $8 million Gamma Knife was co-funded equally by the Victorian Government and through the generous donations to the Peter MacCallum Cancer Foundation.


ESG

Landmark National Health and Climate Strategy to roll out 'green procurement guidelines' for medicines and surgical supplies

Landmark National Health and Climate Strategy to roll out ‘green procurement guidelines’ for medicines and surgical supplies

Health Industry Hub | December 5, 2023 |

ESG: At the 28th United Nations Climate Conference (COP28) in Dubai, Ged Kearney MP, Assistant Minister for Health and Aged […]

More


News & Trends - Pharmaceuticals

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board

Health Industry Hub | December 5, 2023 |

Pharma News: Professor John Skerritt has been appointed as an Independent Selected Director on the Medicines Australia Board effective 4 […]

More


News & Trends - MedTech & Diagnostics

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech

Health Industry Hub | December 5, 2023 |

MedTech & Diagnostics News: In a move aimed at enhancing cystic fibrosis (CF) care and support, Australian-based medical device company, […]

More


News & Trends - Pharmaceuticals

Does the evidence support safety concerns following CAR-T cell therapies?

Does the evidence support safety concerns following CAR-T cell therapies?

Health Industry Hub | December 5, 2023 |

Pharma News: The U.S. Food and Drug Administration (FDA) has launched an investigation into a concerning risk associated with CAR-T […]

More


This content is copyright protected. Please subscribe to gain access.